Who We Are
ICPV membership has grown steadily over the past 5 years.
There are currently over 40 members from all over the UK, as widespread as Southampton to Glasgow and Belfast.
All of our members are either cancer survivors, or have cared for someone with cancer. Some have had both those experiences, and several have been trial participants. We have a wealth of patient experience and a rich mix of professional expertise, with backgrounds in academia, business law , local government, education, corporate communications, healthcare and science.
Because of the nature of our activity and the necessary level of commitment to learn as well as to participate in research, ICPV will not appeal to all cancer patients. We recognise that we are not “representative” – hence our preference for the term “Patient Advocate”.
A full list of members can be found in our latest review
2017 Summer School
The 2017 ICPV Summer School was held over two days in June at Stirling University. The theme of the event was Cancer Survivorship and Living Well Cancer. Click below for details of the course. More details.
A snapsot video of the the 2016 course is now available on YouTube VOICE2016
At the BACR/ECMC conference in July Maggie Wilcox and Mairead Mackenzie were persuaded to speak to the camera. Maggie gave a background to ICPV and our aims and objectives. While Mairead focused on her specific interests and activities. To view follow the links below.
July 2016 Conferences
ICPV members were busy this week with two conferences. The BACR/ECMC Joint Meeting on Therapeutic Interventions for Cancer Prevention was held in Bristol July18-19. The UK Breast Cancer Research Symposium was held in London from July 22-23. Click here for more information.
UK Therapeutic Cancer Prevention Network (UKTCPN)
An update from this new group was presented to the ECMC Annual Network Meeting in May 2016. Click here to download and read.
Call for immediate change to European Paediatric Medicine Regulation to save more lives of children and teens with cancer.
A few basic changes to European Law could speed up access to newer, kinder and potentially better drugs for more children and teenagers with cancer. Click to Sign the petition
Two years on from the start pioneering TRACERx lung cancer study. Click here For the latest news and patient views on this study.